Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis

Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly reported and physicians treating patients with COVID-19-related lung disease need to actively consider these fungal co-infections https://bit.ly/3feuGsQ

Detalles Bibliográficos
Autores principales: Armstrong-James, Darius, Youngs, Jonathan, Bicanic, Tihana, Abdolrasouli, Alireza, Denning, David W., Johnson, Elizabeth, Mehra, Varun, Pagliuca, Tony, Patel, Brijesh, Rhodes, Johanna, Schelenz, Silke, Shah, Anand, van de Veerdonk, Frank L., Verweij, Paul E., White, P. Lewis, Fisher, Matthew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377212/
https://www.ncbi.nlm.nih.gov/pubmed/32703771
http://dx.doi.org/10.1183/13993003.02554-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377212/
https://www.ncbi.nlm.nih.gov/pubmed/32703771
http://dx.doi.org/10.1183/13993003.02554-2020

Ejemplares similares